MTOR and melanoma: Since BRAF signalling belongs to the MAPK signalling pathway and PI3K-AKT-mTOR pathway can provide an alternative survival pathway for melanoma cells, it is important to understand which pathway(s) are activated by growth factors when BRAFV600E is inhibited to gain further insights about the mechanism of BRAF resistance.